Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge
- PMID: 32970125
- DOI: 10.1001/jamaoncol.2020.3946
Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge
Comment in
-
Recurrence of Immune-Related Adverse Events After Immune Checkpoint Inhibitor Rechallenge-Reply.JAMA Oncol. 2020 Nov 1;6(11):1814-1815. doi: 10.1001/jamaoncol.2020.3960. JAMA Oncol. 2020. PMID: 32970107 No abstract available.
Comment on
-
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer.JAMA Oncol. 2020 Jun 1;6(6):865-871. doi: 10.1001/jamaoncol.2020.0726. JAMA Oncol. 2020. PMID: 32297899 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical